Scleral Lenses for GVHD, Stevens-Johnson Syndrome, and Neurotrophic Keratitis

Graft-versus-host disease, Stevens-Johnson syndrome, toxic epidermal necrolysis, and neurotrophic keratitis can create severe ocular surface disease. Patients may experience pain, light sensitivity, foreign body sensation, blurred vision, epithelial breakdown, dryness, scarring, and difficulty functioning day to day. For selected patients, scleral lenses or prosthetic scleral devices may help protect the ocular surface during wear and improve visual function.

These are medically complex conditions. Dr. Edward Boshnick evaluates whether a specialty lens approach is appropriate while recognizing that many patients also need co-management with corneal specialists, transplant physicians, dermatology, rheumatology, oncology, or other medical teams.

Why these conditions are complex

Severe ocular surface disease can affect tear production, eyelid anatomy, corneal sensitivity, epithelial healing, conjunctival health, and corneal clarity. In neurotrophic keratitis, reduced corneal sensation can impair healing and increase risk. In Stevens-Johnson syndrome and ocular GVHD, inflammation and scarring may make the ocular surface fragile and painful.

How scleral lenses may help selected patients

• Surface protection: the lens may shield the cornea from eyelid friction and environmental exposure during wear.
• Fluid reservoir: preservative-free saline beneath the lens may help maintain a moist environment during wear.
• Visual rehabilitation: the lens may create a smoother optical surface when corneal irregularity or scarring affects vision.
• Comfort support: some patients experience less lens awareness because the lens vaults over the cornea and lands on the sclera.

Scleral lenses do not eliminate GVHD, Stevens-Johnson syndrome, toxic epidermal necrolysis, or neurotrophic keratitis. They may help manage comfort and vision in selected cases as part of a broader medical plan.

Dr. Boshnick’s evaluation process

• review of diagnosis, medical history, medications, surgeries, and prior eye treatments
• evaluation of corneal staining, epithelial integrity, scarring, tear film, eyelids, and conjunctiva
• corneal imaging when irregularity or scarring affects vision
• diagnostic scleral lens fitting to assess vault, landing, comfort, and vision
• careful follow-up to monitor ocular surface response and lens safety

Important safety considerations

These conditions can involve fragile tissue, reduced healing, infection risk, inflammation, and reduced corneal sensation. Patients should not self-manage severe ocular surface disease with contact lenses. Specialty lens wear must be prescribed, taught, and monitored carefully.

Frequently asked questions

Can scleral lenses help ocular GVHD?

They may help selected patients with ocular GVHD by protecting the surface and supporting comfort and vision during wear. Medical co-management is often important.

Can scleral lenses help Stevens-Johnson syndrome eye complications?

Some patients with chronic ocular surface damage from Stevens-Johnson syndrome are evaluated for scleral lenses or prosthetic scleral devices. Candidacy depends on the ocular surface, eyelids, scarring, and safety factors.

Can scleral lenses help neurotrophic keratitis?

They may be considered in selected cases, but neurotrophic keratitis requires special caution because reduced corneal sensation can hide injury. Close monitoring is essential.

Related Eye Freedom resources

• Scleral lenses for Sjogren’s and ocular surface disease
• Scleral lenses for dry eye
• Corneal disease
• Scleral lenses
• Request an evaluation

Medical sources

• Peer-reviewed review: Therapeutic Uses of Scleral Contact Lenses for Ocular Surface Disease
• Peer-reviewed study: Mini-scleral lenses in chronic ocular GVHD
• PubMed: Scleral lens fitting in refractory ocular surface disease from SJS/TEN
• NCBI Bookshelf: Neurotrophic Keratitis

This page is educational and is not a diagnosis or treatment plan. A specialty examination and medical supervision are needed for severe ocular surface disease.